Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Acquires Trove Of Rx Safety Data Through Alliance With PatientsLikeMe

Executive Summary

Research collaboration will give FDA access to individual drug safety reports from patient network’s 350,000 members and could lead to future projects on post-market surveillance.

You may also be interested in...



PatientsLikeMe Pioneers Social Medicine

The social media site, now in its second decade, has over 350,000 users who report on more than 2,500 diseases. It has begun partnering with biopharma companies eager to engage with members and mine patient-reported data on diseases and outcomes.

To Improve Adverse Event Tracking, FDA Could Google It

Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse-event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.

To Improve Adverse Event Tracking, FDA Could Google It

Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS056950

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel